z-logo
Premium
Ixazomib cardiotoxicity: A possible class effect of proteasome inhibitors
Author(s) -
Jouni Hayan,
Aubry Mary C.,
Lacy Martha Q.,
Vincent Rajkumar S.,
Kumar Shaji K.,
Frye Robert L.,
Herrmann Joerg
Publication year - 2017
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.24608
Subject(s) - ixazomib , medicine , lenalidomide , cardiotoxicity , dexamethasone , bortezomib , heart failure , multiple myeloma , ejection fraction , prednisone , cardiology , carfilzomib , surgery , chemotherapy

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom